Literature DB >> 18602868

Behavior problems in children with tuberous sclerosis complex and parental stress.

Claudine M C Kopp1, David A Muzykewicz, Brigid A Staley, Elizabeth A Thiele, Margaret B Pulsifer.   

Abstract

Behavioral problems are common in children with tuberous sclerosis complex (TSC) and can be challenging to manage at home. Standardized measures were used to assess behavior in 99 pediatric patients with TSC and to evaluate parenting stress in their parents. About 40% of the pediatric patients presented clinically significant behavioral problems, most frequently involving symptoms of autism spectrum disorder, inattention, and hyperactivity. Higher seizure frequency, mixed seizure disorder, and low intellectual functioning placed the patient at significant risk for behavior problems. Almost 50% of participating parents reported experiencing clinically significant parenting stress, which was associated with specific characteristics of the child, including the presence of current seizures, a history of psychiatric diagnosis, low intelligence, and behavioral problems. Clinicians should be aware that behavioral problems are prominent in children with TSC. Referrals for behavioral intervention and monitoring of parental stress should be included in the medical management of children with TSC.

Entities:  

Mesh:

Year:  2008        PMID: 18602868     DOI: 10.1016/j.yebeh.2008.05.010

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  15 in total

Review 1.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 2.  An approach to cystic kidney diseases: the clinician's view.

Authors:  Christine E Kurschat; Roman-Ulrich Müller; Mareike Franke; David Maintz; Bernhard Schermer; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

3.  Factors affecting epilepsy prognosis in patients with tuberous sclerosis.

Authors:  Gülen Gül Mert; Şakir Altunbaşak; Özlem Hergüner; Faruk İncecik; Hilal Cansever Övetti; Neslihan Özcan; Duygu Kuşçu; İlker Ünal
Journal:  Childs Nerv Syst       Date:  2019-01-23       Impact factor: 1.475

4.  Tuberous sclerosis complex; single center experience.

Authors:  İlknur Erol; Tülin Savaş; Sevda Şekerci; Nalan Yazıcı; Ayşe Erbay; Şenay Demir; Semra Saygı; Özlem Alkan
Journal:  Turk Pediatri Ars       Date:  2015-03-01

Review 5.  Molecular therapies for tuberous sclerosis and neurofibromatosis.

Authors:  David Neal Franz; Brian D Weiss
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

6.  Parental stress and adjustment in the context of rare genetic syndromes: A scoping review.

Authors:  Jacqueline Fitzgerald; Louise Gallagher
Journal:  J Intellect Disabil       Date:  2021-04-19

7.  A cross-syndrome cohort comparison of sleep disturbance in children with Smith-Magenis syndrome, Angelman syndrome, autism spectrum disorder and tuberous sclerosis complex.

Authors:  J Trickett; M Heald; C Oliver; C Richards
Journal:  J Neurodev Disord       Date:  2018-03-01       Impact factor: 4.025

8.  Autism spectrum disorder in tuberous sclerosis complex: searching for risk markers.

Authors:  Aglaia Vignoli; Francesca La Briola; Angela Peron; Katherine Turner; Chiara Vannicola; Monica Saccani; Elisabetta Magnaghi; Giulia Federica Scornavacca; Maria Paola Canevini
Journal:  Orphanet J Rare Dis       Date:  2015-12-02       Impact factor: 4.123

Review 9.  Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis.

Authors:  Teguh Haryo Sasongko; Nur Farrah Dila Ismail; Nik Mohamad Ariff Nik Abdul Malik; Z A M H Zabidi-Hussin
Journal:  Orphanet J Rare Dis       Date:  2015-08-12       Impact factor: 4.123

10.  Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers.

Authors:  Kate E Eden; Petrus J de Vries; Jo Moss; Caroline Richards; Chris Oliver
Journal:  J Neurodev Disord       Date:  2014-05-10       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.